Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe web page has updated its version from v2.16.4 to v2.16.5, while a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest has been removed.SummaryDifference0.6%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check46 days agoChange DetectedThe page has removed a citation regarding the incidence trends in primary malignant penile cancer, including an erratum correction.SummaryDifference0.3%
- Check60 days agoChange DetectedThe page has removed a citation for a Phase III study on chemotherapy for locally advanced head and neck cancer, which was previously included.SummaryDifference0.2%
Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.